Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNCDSS for Inpatient Glucose Control
NCT04517201Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Fasting plasma glucose at 7 days. Status: unknown.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04517201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04517201.